ArticleInternal medicine (Tokyo, Japan)2020

Implications for White Matter Vulnerability to Anti-interleukin-6 Receptor Antibody Treatment.

Daisuke KatoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.